Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Metagenomi, Inc. Common Stock
MGXCurrent price
1.88 USD
-0.42 USD (-18.26%)
Last closed
2.21 USD
Company
www.metagenomi.co
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
101 058 304 USD
Yield for 12 month
-87.47 %
1Y
3Y
5Y
10Y
15Y
MGX
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California. Address: 5959 Horton Street, Emeryville, CA, United States, 94608
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17 USDP/E ratio
–Dividend Yield
–Current Year
+44 756 000 USD
Last Year
+17 200 000 USD
Current Quarter
+20 008 000 USD
Last Quarter
+11 159 000 USD
Current Year
+40 549 000 USD
Last Year
+15 467 000 USD
Current Quarter
+18 699 000 USD
Last Quarter
+9 886 000 USD
Key Figures MGX
1 year
3 years
5 years
10 years
EBITDA
-83 549 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.92 %
PEG Ratio
–
Return On Equity TTM
-28.98 %
Wall Street Target Price
17 USD
Revenue TTM
55 929 000 USD
Book Value
7.19 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
76.5 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2 USD
Diluted Eps TTM
-2 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-134.1 %
Dividend Analytics MGX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MGX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MGX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
1.8069
Enterprise Value EBITDA
–
Price Book MRQ
0.3751
Financials MGX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MGX
For 52 weeks
1.85 USD
15 USD
50 Day MA
3.67 USD
Shares Short Prior Month
272 953
200 Day MA
6.8 USD
Short Ratio
2.17
Shares Short
369 490
Short Percent
0.81 %
BeatStart